UFC’s Gleison Tibau Notified of Second Drug Test Failure
By FCF Staff
Earlier in December, U.S. Anti-Doping Agency (USADA) announced that Gleison Tibau had been flagged for a potential, anti-doping violation from an out-of-competition test, and now it’s reporting the UFC vet has potential violation from another test as well.
Recently the UFC posted the following statement on its official website:
The U.S. Anti-Doping Agency (USADA) has notified both Gleason Tibau and UFC of a potential Anti-Doping Policy violation stemming from an in-competition sample collected immediately after his bout in Sao Paulo, Brazil on November 7, 2015. Tibau and UFC were previously notified that he had been provisionally suspended due to a potential Anti-Doping Policy violation stemming from an out-of-competition test.
USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case involving Tibau. Additional information will be provided at the appropriate time as the process moves forward.
Following the announcement regarding the out-of-competition test, Tibau denied knowingly taking any banned substance. The 32 year-old fighter is coming off a submission win over Abel Trujillo, but that result could be overturned.